Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer
PHASE3CompletedINTERVENTIONAL
Enrollment
459
Participants
Timeline
Start Date
April 25, 2014
Primary Completion Date
October 20, 2017
Study Completion Date
November 23, 2018
Conditions
Recurrent or Metastatic Head and Neck Carcinoma
Interventions
DRUG
Vinflunine
DRUG
Methotrexate
Trial Locations (1)
Unknown
Institut de Recherche Pierre Fabre, Toulouse
All Listed Sponsors
lead
Pierre Fabre Medicament
INDUSTRY
NCT02347332 - Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter